Adeno-Associated Virus (AAV) gene therapy has emerged as a groundbreaking approach in the treatment of various genetic and acquired disorders. In the United States, the field has seen remarkable advancements, with numerous clinical trials and FDA approvals highlighting its potential to revolutionize healthcare. This blog explores the current landscape of AAV gene therapy in the U.S., focusing...